Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
37 studies found for:    " August 07, 2013":" September 06, 2013"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" August 07, 2013":" September 06, 2013"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Unknown  Safety and Immunological Response of a Boosting Dose of MVA-B in Healthy Volunteers After 4 Years of Receiving MVA-B
Condition: HIV Infections
Intervention: Biological: Experimental
2 Recruiting A Phase 1, Randomized, Blinded, Dose-escalation Study of rAAV1-PG9DP Recombinant AAV Vector Coding for PG9 Antibody in Healthy Male Adults.
Condition: HIV Infections
Intervention: Biological: rAAV1-PG9DP
3 Completed Advanced Neuroimaging Evaluation of the Central Nervous System Biological Changes Associated With Efavirenz Therapy and Switch to an Elvitegravir-based Regimen
Condition: HIV Disease
Intervention: Drug: Stribild (elvitegravir, cobicistat, emtricitabine and tenofovir)
4 Unknown  IL-23/IL-12 Imbalance and T Lymphocyte Polarization in HIV Infection
Condition: HIV Reservoirs
Intervention: Other: Blood sample and recto-colic biopsies
5 Recruiting Study of Immune Responses Induced by a HIV Vaccine
Condition: HIV Infections
Interventions: Biological: AIDSVAX B/E;   Biological: AIDSVAX B/E Placebo
6 Recruiting Evaluating the Safety and Efficacy of Romidepsin in Combination With Antiretroviral Therapy in HIV-Infected Adults With Suppressed Viral Load
Condition: HIV Infections
Interventions: Drug: Romidepsin;   Drug: Placebo for RMD: 0.9% sodium chloride for injection
7 Active, not recruiting Study of Boosting Strategies After Vaccination With ALVAC-HIV and AIDSVAX® B/E
Condition: HIV Infections
Interventions: Biological: ALVAC-HIV;   Biological: AIDSVAX B/E;   Biological: ALVAC-HIV Placebo;   Biological: AIDSVAX B/E Placebo
8 Withdrawn Evaluating the Safety and Immune Response to Two HIV Vaccine Regimens in Healthy, HIV-Uninfected Adults in the United States and South Africa
Condition: HIV Infections
Interventions: Biological: DNA-HIV-PT123 vaccine;   Biological: NYVAC-HIV-PT1 vaccine;   Biological: NYVAC-HIV-PT4 vaccine;   Biological: AIDSVAX B/E vaccine;   Biological: Placebo for DNA/NYVAC/AIDSVAX
9 Completed
Has Results
A Pharmacokinetic Study to Evaluate the Effect of MAALOX on Raltegravir (MK-0518) in Human Immunodeficiency Virus (HIV)-Infected Participants (MK-0518-295)
Condition: HIV Infections
Interventions: Drug: Raltegravir (ISENTRESS™);   Drug: MAALOX (MAL)
10 Recruiting A Comprehensive Approach to Secondary HIV Prevention and Care Among Positives
Condition: HIV
Interventions: Behavioral: Prevention & Testing;   Behavioral: Prevention & Testing Control
11 Active, not recruiting Two Part Study to Evaluate Pharmacokinetics, Safety, and Antiviral Activity of Elvitegravir Administered With a PI/r Background Regimen for ARV Treatment-Experienced Pediatric Participants
Conditions: Acquired Immune Deficiency Syndrome (AIDS);   HIV Infections
Interventions: Drug: EVG;   Drug: Background regimen
12 Completed Determining the Barriers and Motivations to Clinical Trial Participation
Condition: HIV
Intervention:
13 Unknown  The ACCLAIM Project
Condition: HIV
Interventions: Behavioral: Community leader engagement;   Behavioral: Community days;   Behavioral: Community Peer Groups
14 Active, not recruiting ENGAGE4HEALTH: A Combination Intervention Strategy for Linkage and Retention in Mozambique
Condition: HIV
Interventions: Other: Point of care CD4+ after HIV diagnosis;   Other: Accelerated ART initiation;   Behavioral: SMS appointment reminders;   Other: Non-cash Financial Incentives
15 Active, not recruiting Zinc for HIV Disease Among Alcohol Users - an RCT in the Russia ARCH Cohort
Conditions: HIV Infection;   Alcohol Use
Interventions: Dietary Supplement: Zinc gluconate;   Dietary Supplement: Placebo
16 Active, not recruiting The Impact of Mentor Mothers on PMTCT Service Outcomes in Nigeria
Condition: HIV
Intervention: Behavioral: Trained Mentor Mother and Supervisor
17 Active, not recruiting Strategies to Optimize Antiretroviral Therapy Services for Maternal & Child Health: the MCH-ART Study
Condition: HIV
Intervention: Other: MCH-focused ART services
18 Recruiting HBV-HIV Coinfection Research Network
Conditions: Hepatitis B;   Human Immunodeficiency Virus
Intervention:
19 Completed An Exploratory Study of Potential Sources of Efficacy Dilution in the VOICE Trial (MTN-003)
Condition: HIV Prevention
Intervention: Behavioral: Focus Group Discussions and In-Depth Interviews
20 Unknown  Individualized Triple-therapy Using Boceprevir in HIV-positive Patients With Hepatitis C
Conditions: Hepatitis C, Chronic;   HIV
Interventions: Drug: Pegylated interferon alpha-2a;   Drug: Ribavirin;   Drug: Boceprevir

   Previous Page Studies Shown (1-20) Next Page (21-37) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.